{"id":947712,"date":"2026-03-30T16:42:04","date_gmt":"2026-03-30T20:42:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/"},"modified":"2026-03-30T16:42:04","modified_gmt":"2026-03-30T20:42:04","slug":"levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/","title":{"rendered":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, March  30, 2026  (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0<strong>Mereo BioPharma Group plc<\/strong> (&#8220;Mereo&#8221; or the &#8220;Company&#8221;) (NASDAQ: MREO) of a class action securities lawsuit.<\/p>\n<p align=\"left\">\n        <strong>CLASS DEFINITION: <\/strong>The lawsuit seeks to recover losses on behalf of Mereo investors who were adversely affected by alleged securities fraud between June 5, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O2ZcTCi_suDwQNN788P6nh9f-8uY1wXHjJ7T7OmqnfpQpP1eik4TTNg_Z6rnLb48nRUxiQlcfV9WwdBb-cnjke0xQdRrrOHtkTKg_02Jw18WwW3Aec5tvtttGAQ-FBSE6T_tps8k5t6JkcGc0y1AIre-RK4ysUcU89OEgb-sRI2QIm8EDi68LIybHMICf3qSyJW637u8PTErltarqCYpvUs41BWxODL-a5CXU3WmsJqsPQ3Xdw9QlzQGlq2N4oQmgTNL-ymWeyZ09l_set6l5KycjcnfupeLG02fepLuPnA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/zlk.com\/pslra-1\/mereo-biopharma-group-plc-lawsuit-submission-form-2?prid=184920&amp;wire=3<\/a>\n      <\/p>\n<p align=\"left\">\n        <strong>MREO<\/strong> investors may also contact Joseph E. Levi, Esq. via email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g5m9AQuLaNeWFG3elQcVepVXjplv8FATmpfXOq3McgQwNpJ5V4BAIrj3KnM4ceuGxoSHmjUNLZqk7HDki_kc7HTG6GSYl5j-_tPdHBqEHK4=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a> or by telephone at (212) 363-7500.<\/p>\n<p align=\"left\">\n        <strong>CASE DETAILS: <\/strong>According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and\/or concealing material adverse facts concerning the true state of the Phase 3 ORBIT and COSMIC programs; neither of which hit its primary endpoints of reducing annualized clinical fracture rate compared to the placebo or bisphosphonate control groups, respectively. On December 29, 2025, Mereo issued a press release announcing that neither the ORBIT nor the COSMIC Phase 3 studies achieved statistical significance. The press release indicated that neither study met its primary endpoint of reduction in annualized clinical fracture rate compared to placebo or bisphosphonates, respectively, despite improved bone mineral density. Following this news, the price of Mereo\u2019s ADS declined dramatically. From a closing market price of $2.31 per share on December 26, 2025, Mereo\u2019s ADS price fell to $0.29 per share on December 29, 2025, a decline of more than 87.7%.<\/p>\n<p align=\"left\">\n        <strong>WHAT&#8217;S NEXT? <\/strong>If you suffered a loss in Mereo during the relevant time frame, you have until <strong>April 6, 2026<\/strong>\u00a0to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn&#8217;t require that you serve as a lead plaintiff.<\/p>\n<p align=\"left\">\n        <strong>NO COST TO YOU: <\/strong>If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. <strong>There is no cost or obligation to participate.<\/strong><\/p>\n<p align=\"left\">\n        <strong>WHY LEVI &amp; KORSINSKY: <\/strong>Over the past 20 years, the team at Levi &amp; Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services\u2019 Top 50 Report as one of the top securities litigation firms in the United States.<\/p>\n<p align=\"left\">\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>Levi &amp; Korsinsky, LLP <br \/>Joseph E. Levi, Esq.<br \/>Ed Korsinsky, Esq.<br \/>33 Whitehall Street, 27th Floor<br \/>New York, NY 10004<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g5m9AQuLaNeWFG3elQcVepVXjplv8FATmpfXOq3McgRsKfNTsSbVRcu6wU3eeQGRgsv37VzPY6JJtdvqAgPOMzphk9pPLJHH_DAKC6J7Y6Q=\" rel=\"nofollow\" target=\"_blank\">jlevi@levikorsinsky.com<\/a><br \/>Tel: (212) 363-7500<br \/>Fax: (212) 363-7171<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M-nRd_rJ6H4oiamJvv0XzhfxEsXdjQn8fQBsVU9jTlXnapu58Nu_DBV_yesAbWmBlmRznvXIAABSF9KS1RG--A==\" rel=\"nofollow\" target=\"_blank\">www.zlk.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTMxY2NmYjYtYzA2Zi00NzI2LTljYTItY2RjY2M4NzQxM2RiLTEwMzIyOTMtMjAyNi0wMy0zMC1lbg==\/tiny\/Levi-Korsinsky-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Mereo BioPharma Group plc (&#8220;Mereo&#8221; or the &#8220;Company&#8221;) (NASDAQ: MREO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Mereo investors who were adversely affected by alleged securities fraud between June 5, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/mereo-biopharma-group-plc-lawsuit-submission-form-2?prid=184920&amp;wire=3 MREO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-947712","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Mereo BioPharma Group plc (&#8220;Mereo&#8221; or the &#8220;Company&#8221;) (NASDAQ: MREO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Mereo investors who were adversely affected by alleged securities fraud between June 5, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/mereo-biopharma-group-plc-lawsuit-submission-form-2?prid=184920&amp;wire=3 MREO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements &hellip; Continue reading &quot;Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-30T20:42:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders\",\"datePublished\":\"2026-03-30T20:42:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/\"},\"wordCount\":456,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/\",\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\",\"datePublished\":\"2026-03-30T20:42:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk","og_description":"NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) &#8212; Levi &amp; Korsinsky, LLP notifies investors in\u00a0Mereo BioPharma Group plc (&#8220;Mereo&#8221; or the &#8220;Company&#8221;) (NASDAQ: MREO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Mereo investors who were adversely affected by alleged securities fraud between June 5, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team: https:\/\/zlk.com\/pslra-1\/mereo-biopharma-group-plc-lawsuit-submission-form-2?prid=184920&amp;wire=3 MREO investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements &hellip; Continue reading \"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-30T20:42:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders","datePublished":"2026-03-30T20:42:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/"},"wordCount":456,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/","name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=","datePublished":"2026-03-30T20:42:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4MDc2MiM3NTEwMTY2IzIwMjA0MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/levi-korsinsky-announces-the-filing-of-a-securities-class-action-on-behalf-of-mereo-biopharma-group-plc-mreo-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Mereo BioPharma Group plc (MREO) Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/947712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=947712"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/947712\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=947712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=947712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=947712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}